menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Managing Chronic Hepatitis B: Integrating Eastern Philosophies with Western Approaches

close
0.50 credits
30 minutes
ReachMD Healthcare Image
Restart
Resume
Read full article
Choose a format
Get your free creditsSkip straight to the post-test if you have already participated in this activity
Media formats available:
0.50 credits
A pre-test is required to view this content.
A pre-survey is required to view this content.
Details
Presenters
Related
Comments
  • Overview

    Experts in chronic hepatitis B within Asian communities discuss prevention, screening and management options to reduce the number of new cases and the risk of progression to cirrhosis, hepatic failure, and hepatocellular carcinoma. Experts also will consider the integration of Western and Eastern Medicine approaches to treatment and how cultural perceptions and community stigmatization of persons of Asian descent with chronic HBV infection can create barriers to diagnosis and care.

  • Disclosure of Conflicts of Interest

    Asian Health Foundation, Chinese Hospital and Global Education Group (Global) require instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

    The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

    Name of Faculty or Presenter

    Reported Financial Relationship

     Mindie Nguyen

    Consultant/Advisory Board: Eli Lilly, Exact Sciences,  Janssen, Novartis, Spring Bank, VIR

    Research Grant: Gilead Sciences, VIR

    Danny Chu

    Speaker: Gilead Sciences

    Joseph Lim

    Research Grant to Yale: Allergan, Celgene, Genfit, Gilead, Intercept

    Jian Q. Zhang

    Nothing to disclose

    The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

    Name of Planner or Manager

    Reported Financial Relationship

    Patricia Chung

    Nothing to disclose

    Jennifer Kuang

    Nothing to disclose

    Liddy Knight

    Nothing to disclose

    Ashley Marostica

    Nothing to disclose

    Ashley Cann

    Nothing to disclose

    Andrea Funk

    Nothing to disclose

    Jocelyn Woog

    Nothing to disclose

    Raquel Da Rosa

    Nothing to disclose

    Joanne Jablonski

    Nothing to disclose

    Scott Huang, DO

    Individual Stock Holder: Gilead Sciences, Inc.

  • Target Audience

    HCPs practicing in Asian American communities, including MDs, DOs, NPs, PAs, and RNs

  • Learning Objectives

    After completing this activity, participants will be better able to:

    1. Apply knowledge of the high prevalence of HBV in Asian communities to deploy best practices for prevention, screening, and treatment to reduce new cases of hepatitis B, rates of CHB, and progression to HCC.
    2. Describe the differences between Western and Eastern medicine including traditional Chinese medicine with respect to the definition, causes, clinical features, treatment and prevention of CHB.
    3. Discuss how differences between Western and Eastern medicine can influence screening, diagnosis and management of patients with CHB.
    4. Recommend the rational combined use of Western HBV pharmacotherapy such as nucleos(t)ide analogs and Eastern treatment such as Traditional Chinese Medicine including herbs and acupuncture.
    5. Integrate into practice how cultural perceptions of HBV infection and community stigmatization of persons of Asian descent with CHB can create barriers to screening and management.
  • Accreditation and Credit Designation Statements

    Physician Accreditation Statement
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the California Medical Association (CMA) through the  joint providership of Chinese Hospital and Asian Health Foundation.  The Chinese Hospital is accredited by the CMA to provide continuing medical education for physicians.

    Physician Credit Designation
    The Chinese Hospital designates this educational activity for a maximum of .50 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. This credit may also be applied to the CMA certification in Continuing Medical Education.

    Nursing Accreditation
    Global Education Group is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

    This educational activity for 0.50 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

  • Providers

    ReachMD Healthcare Image

    ReachMD Healthcare Image

    ReachMD Healthcare Image

    ReachMD Healthcare Image

  • Commercial Support

    This continuing medical education activity is supported by an independent educational grant from Gilead Sciences, Inc.

    This activity is jointly provided by the Asian Health Foundation and Chinese Hospital.

    This activity is jointly provided for nursing credit by the Asian Health Foundation and Global Education Group.

  • Contact Information

    Chinese Hospital Information
    For information about the physician accreditation of this program, please contact Chinese Hospital at jenniferk@chasf.org

    Global Contact Information
    For information about the nursing accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com

    Asian Health Foundation Information
    For more information about the Asian Health Foundation, please contact Jocelyn Woog at asianhealthfoundation@charter.net

  • Term of Offering

    This activity was released on May 1, 2021 and is valid for one year. Requests for credit must be made no later than May 1, 2022.

  • Fee Information& Refund/Cancellation Policy

    There is no fee for this educational activity.

  • Disclaimer

    Disclosure of Unlabeled Use
    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Chinese Hospital, Global Education Group (Global) and the Asian Health Foundation do not recommend the use of any agent outside of the labeled indications. 

    The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

    Disclaimer
    Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

  • Publication Dates

    Release Date:

    Expiration Date:

Facebook Comments

Recommended
Details
Presenters
Related
Comments
  • Overview

    Experts in chronic hepatitis B within Asian communities discuss prevention, screening and management options to reduce the number of new cases and the risk of progression to cirrhosis, hepatic failure, and hepatocellular carcinoma. Experts also will consider the integration of Western and Eastern Medicine approaches to treatment and how cultural perceptions and community stigmatization of persons of Asian descent with chronic HBV infection can create barriers to diagnosis and care.

  • Disclosure of Conflicts of Interest

    Asian Health Foundation, Chinese Hospital and Global Education Group (Global) require instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

    The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

    Name of Faculty or Presenter

    Reported Financial Relationship

     Mindie Nguyen

    Consultant/Advisory Board: Eli Lilly, Exact Sciences,  Janssen, Novartis, Spring Bank, VIR

    Research Grant: Gilead Sciences, VIR

    Danny Chu

    Speaker: Gilead Sciences

    Joseph Lim

    Research Grant to Yale: Allergan, Celgene, Genfit, Gilead, Intercept

    Jian Q. Zhang

    Nothing to disclose

    The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

    Name of Planner or Manager

    Reported Financial Relationship

    Patricia Chung

    Nothing to disclose

    Jennifer Kuang

    Nothing to disclose

    Liddy Knight

    Nothing to disclose

    Ashley Marostica

    Nothing to disclose

    Ashley Cann

    Nothing to disclose

    Andrea Funk

    Nothing to disclose

    Jocelyn Woog

    Nothing to disclose

    Raquel Da Rosa

    Nothing to disclose

    Joanne Jablonski

    Nothing to disclose

    Scott Huang, DO

    Individual Stock Holder: Gilead Sciences, Inc.

  • Target Audience

    HCPs practicing in Asian American communities, including MDs, DOs, NPs, PAs, and RNs

  • Learning Objectives

    After completing this activity, participants will be better able to:

    1. Apply knowledge of the high prevalence of HBV in Asian communities to deploy best practices for prevention, screening, and treatment to reduce new cases of hepatitis B, rates of CHB, and progression to HCC.
    2. Describe the differences between Western and Eastern medicine including traditional Chinese medicine with respect to the definition, causes, clinical features, treatment and prevention of CHB.
    3. Discuss how differences between Western and Eastern medicine can influence screening, diagnosis and management of patients with CHB.
    4. Recommend the rational combined use of Western HBV pharmacotherapy such as nucleos(t)ide analogs and Eastern treatment such as Traditional Chinese Medicine including herbs and acupuncture.
    5. Integrate into practice how cultural perceptions of HBV infection and community stigmatization of persons of Asian descent with CHB can create barriers to screening and management.
  • Accreditation and Credit Designation Statements

    Physician Accreditation Statement
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the California Medical Association (CMA) through the  joint providership of Chinese Hospital and Asian Health Foundation.  The Chinese Hospital is accredited by the CMA to provide continuing medical education for physicians.

    Physician Credit Designation
    The Chinese Hospital designates this educational activity for a maximum of .50 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. This credit may also be applied to the CMA certification in Continuing Medical Education.

    Nursing Accreditation
    Global Education Group is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

    This educational activity for 0.50 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

  • Providers

    ReachMD Healthcare Image

    ReachMD Healthcare Image

    ReachMD Healthcare Image

    ReachMD Healthcare Image

  • Commercial Support

    This continuing medical education activity is supported by an independent educational grant from Gilead Sciences, Inc.

    This activity is jointly provided by the Asian Health Foundation and Chinese Hospital.

    This activity is jointly provided for nursing credit by the Asian Health Foundation and Global Education Group.

  • Contact Information

    Chinese Hospital Information
    For information about the physician accreditation of this program, please contact Chinese Hospital at jenniferk@chasf.org

    Global Contact Information
    For information about the nursing accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com

    Asian Health Foundation Information
    For more information about the Asian Health Foundation, please contact Jocelyn Woog at asianhealthfoundation@charter.net

  • Term of Offering

    This activity was released on May 1, 2021 and is valid for one year. Requests for credit must be made no later than May 1, 2022.

  • Fee Information& Refund/Cancellation Policy

    There is no fee for this educational activity.

  • Disclaimer

    Disclosure of Unlabeled Use
    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Chinese Hospital, Global Education Group (Global) and the Asian Health Foundation do not recommend the use of any agent outside of the labeled indications. 

    The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

    Disclaimer
    Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

  • Publication Dates

    Release Date:

    Expiration Date:

Facebook Comments

Programs 9/17/21